NAGE Niagen Bioscience, Inc.
P/E
13.26
Forward P/E
16.86
Price/Sales
1.545
Beta
2.084
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Niagen Bioscience's second quarter revenue misses estimates while strong DTC growth supports in-line EPS.
Niagen Bioscience reported second quarter 2026 net sales of $29.8 million, missing analyst expectations, while diluted earnings per share came in at $0.01,...
Niagen Bioscience, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Analysts expect Niagen Bioscience to report Q2 2026 revenue of approximately $32.00 million and earnings per share of $0.01, while the stock currently trades...